van der Wal Martje H L, Hjelmfors Lisa, Strömberg Anna, Jaarsma Tiny
Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
ESC Heart Fail. 2020 Jun;7(3):878-882. doi: 10.1002/ehf2.12672. Epub 2020 Mar 11.
According to guidelines, a prognosis should be discussed with all heart failure (HF) patients. However, many patients do not have these conversations with a healthcare provider. The aim of this study was to describe attitudes of cardiologists in Sweden and the Netherlands regarding this topic.
A survey was sent to 250 cardiologists in Sweden and the Netherlands with questions whether should the prognosis be discussed, what time should the prognosis be discussed, whom should discuss, what barriers were experienced and how difficult it is to discuss the prognosis (scale from 1-10). A total of 88 cardiologists participated in the study. Most cardiologists (82%) reported to discussing the prognosis with all HF patients; 47% at the time of diagnoses. The patient's own cardiologist, another cardiologist, the HF nurse, or the general practitioner could discuss this with the patient. Important barriers were cognitive problems (69%) and a lack of time (64%). Cardiologists found it not very difficult to discuss the topic (mean score 4.2) with a significant difference between Swedish and Dutch cardiologist (4.7 vs. 3.7; P < 0.05).
Most cardiologists found it important to discuss the prognosis with HF patients although there are several barriers. Swedish cardiologists found it more difficult compared with their Dutch colleagues. A multidisciplinary approach seems important for improvement of discussing prognosis with HF patients.
根据指南,应与所有心力衰竭(HF)患者讨论预后情况。然而,许多患者并未与医疗服务提供者进行此类对话。本研究的目的是描述瑞典和荷兰心脏病专家对该主题的态度。
向瑞典和荷兰的250名心脏病专家发送了一份调查问卷,问题包括是否应讨论预后、应在何时讨论预后、应由谁来讨论、遇到了哪些障碍以及讨论预后的难度如何(从1至10评分)。共有88名心脏病专家参与了该研究。大多数心脏病专家(82%)报告称会与所有HF患者讨论预后;47%在诊断时进行讨论。患者自己的心脏病专家、另一位心脏病专家、HF护士或全科医生可以与患者讨论此事。重要障碍包括认知问题(69%)和时间不足(64%)。心脏病专家发现讨论该主题并非非常困难(平均得分4.2),瑞典和荷兰心脏病专家之间存在显著差异(4.7对3.7;P<0.05)。
尽管存在一些障碍,但大多数心脏病专家认为与HF患者讨论预后很重要。与荷兰同行相比,瑞典心脏病专家发现此事更具难度。多学科方法对于改善与HF患者讨论预后似乎很重要。